CPL304110
CPL304110 is a potent, orally active and selective inhibitor of fibroblast growth factor receptors FGFR (1-3), with IC50 values of 0.75 nM, 0.5 nM, and 3.05 nM for FGFR (1-3), respectively[1].
Product Specifications
CAS Number
[1627826-19-0]
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cpl304110.html
Purity
99.85
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN(CC1)CCN1C2=CC3=C(N=C(C4=NNC(CCC5=CC(OC)=CC(OC)=C5)=C4)N3)C=C2
Molecular Formula
C25H30N6O2
Molecular Weight
446.54
References & Citations
[1]Abdellah Yamani, et al. Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1-3) . Eur J Med Chem. 2020 Nov 7;112990.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15231106 1 Vial
Lentiviral mouse Vmn1r173 shRNA (UAS) - Lentiviral mouse Vmn1r173 shRNA (UAS, GFP) plasmid
Ask
View Details 413040-01 2.5 mg
2- (2-Amino-1,1-dioxidothiazol-4-yl) -N- (4- (2-aminoethyl) phenyl) acetamide Hydrochloride
Ask
View Details 413040-02 5 mg
2- (2-Amino-1,1-dioxidothiazol-4-yl) -N- (4- (2-aminoethyl) phenyl) acetamide Hydrochloride
Ask
View Details 